Paragon 28, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG005914H31
FNA
Paragon 28, Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Devices
NAME
Paragon 28, Inc.
ISIN
US69913P1057
TICKER
FNA
MIC
XNYS
REUTERS
FNA.N
BLOOMBERG
FNA US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 13.01.2025
Paragon 28
US69913P1057
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2024.
Preliminary unaudited net revenue for the fourth quarter of 2024 is expe...
Paragon 28
Fri, 03.01.2025
Paragon 28
US69913P1057
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 7:30 a.m. Pac...
Paragon 28
Wed, 11.12.2024
Paragon 28
US69913P1057
Paragon 28, Inc. (NYSE: FNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition...
Paragon 28
Fri, 29.11.2024
Paragon 28
US69913P1057
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSE: FNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Inves...
Paragon 28
Fri, 29.11.2024
Paragon 28
US69913P1057
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) and reminds investors of the November 29, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &a...
Paragon 28
Mon, 18.11.2024
Paragon 28
US69913P1057
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will participate in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time...
Paragon 28
Tue, 12.11.2024
Paragon 28
US69913P1057
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended September 30, 2024 and raised its 2024 net revenue guidance.
Recent Business Updates
Recorded global net revenue of $62.3 million in the ...
Paragon 28
Wed, 23.10.2024
Paragon 28
US69913P1057
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) securities during the period of May 5, 2023 through August 8, 2024, inclusive (“the Class Period”). Inv...
Paragon 28
Sat, 19.10.2024
Paragon 28
US69913P1057
Hagens Berman announces that the firm and additional counsel have filed a new class action lawsuit against Paragon 28, Inc. (NYSE: FNA) and certain of its senior executives.
The new complaint extends the alleged fraudulent period in the pending litigation against Paragon 28, contending that Paragon 28’s stock was artificially inflated by Defendan...
Paragon 28
Thu, 17.10.2024
Paragon 28
US69913P1057
The Denver Law Office of Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Paragon 28, Inc. (NYSE: FNA) a company headquartered in Englewood, Colorado. The lawsuit, filed in U.S. District Court, District of Colorado, docket #1:24-cv-02712, seeks to recover losses on behalf of investors who acquired b...
Paragon 28
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
